EVO
Evotec SE
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · DE
$1.60
−4.19%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.31
- Revenue estimate
- $167.2M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.05
- Revenue actual
- $166.7M
- Revenue estimate
- $174.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 11
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -118.5%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.05 | -$0.17 | Miss -275.40% | $166.7M |
| May 6, 2026 | -$0.15 | -$0.48 | Miss -217.27% | $216.1M |
| Nov 5, 2025 | -$0.14 | -$0.14 | Miss -1.44% | $192.0M |
| Aug 13, 2025 | -$0.18 | -$0.14 | Beat 19.93% | $201.6M |
| Apr 17, 2025 | $0.02 | -$0.12 | Miss -768.15% | $229.1M |
| Aug 14, 2024 | -$0.09 | -$0.29 | Miss -222.22% | $195.8M |
| May 22, 2024 | -$0.03 | -$0.05 | Miss -49.52% | $224.2M |
| Feb 26, 2024 | -$0.03 | -$0.05 | Miss -66.67% | $221.4M |
| Aug 29, 2023 | -$0.04 | -$0.04 | Miss -10.93% | $185.8M |
| May 12, 2023 | $0.10 | -$0.08 | Miss -180.00% | $232.2M |
| Aug 11, 2022 | -$0.02 | -$0.08 | Miss -375.06% | $180.1M |
| Apr 12, 2022 | $0.07 | -$0.11 | Miss -257.14% | $212.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026